How Modern LPAs Handle Cross-Fund Investments

A general partner rarely needs permission to like a company twice. The harder question is what happens when the same sponsor puts Fund III money into a business Fund II already owns, or sells an asset from one of its funds to another. Cross-Fund Investments in LPAs are usually managed rather than banned. ILPA defines cross-fund investing as a firm investing in the same company at different times from different funds, such as using a current fund to finance a company already held by an earlier fund. Contemporary institutional fund documents rarely prohibit this outright. Instead, they control the situation through allocation rules, conflict procedures, advisory committee review, valuation support and disclosure. The drafting question is whether limited partners can test the judgement afterwards.

The five LPA controls

Most limited partnership agreements handle cross-fund activity through a combination of mechanisms rather than a single clause. Each control addresses a different part of the same conflict, from whether the investment is allowed to how the price is supported.

• Permitted investments and follow-on authority, which set whether the fund may deploy capital into an asset an affiliate already holds.
• Investment allocation policy, which decides which vehicle gets the opportunity and in what proportion.
• Conflict-of-interest provisions, including disclosure and limited partner advisory committee, or LPAC, review, consultation, waiver or consent.
• Valuation and process protections, from third-party price discovery to independent valuation or fairness opinions.
• Reporting obligations, side letters and most-favoured-nation, or MFN, rights that extend negotiated protections to other investors.

Carta notes that managers offering co-investment rights should maintain an investment allocation policy governing how deals are split among the fund, overlapping funds and co-investors. The same policy carries much of the weight in cross-fund cases because it turns a broad permission into an operational decision rule.

Cross-fund transaction scope

The narrow definition covers sequential investment in one company from two vehicles. The broader category, as set out by Houlihan Lokey, includes mergers of portfolio companies held in different funds, sales of a portfolio company from one sponsor-managed fund to another, subsequent-fund equity supporting an acquisition by an existing portfolio company, and carve-outs or divestitures from existing portfolio companies.

Take the acquisition case as a labelled hypothetical. A Fund II portfolio company signs a bolt-on that requires fresh equity. Fund II is past its investment period and short on reserves. Fund III, which shares the strategy, funds the equity cheque at an agreed entry price. Two funds now hold economic interests in the same business, set by a price the sponsor influenced on both sides.

Cross-fund investment, co-investment, parallel fund and continuation vehicle

The categories overlap in practice. A continuation fund is a species of related-party transfer, and academic work by Kastiel and Nili argues that many LPAs lack terms protecting LP interests in continuation-fund transactions. That critique is specific to continuation vehicles and should not be stretched to every ordinary follow-on across funds.

Clause map inside the LPA

Cross-fund issues appear across the document rather than under a single heading. A useful review maps them by function, because the economic permission, conflict process and disclosure obligation may sit in different parts of the agreement.

• Investment objective and permitted investments: whether an asset already owned by an affiliate is eligible.
• Follow-on authority: whether capital may be deployed after the investment period ends and against which limits.
• Successor-fund provisions: Proskauer has noted that fund agreements may permit a successor fund sharing the same strategy to make cross-over investments in prior-fund portfolio companies.
• Allocation policy: referenced in the LPA, usually detailed in a separate written policy.
• Conflicts and affiliate transactions: the operative consent or waiver machinery.
• LPAC mandate: composition, quorum, voting standard and scope of authority.
• Valuation policy: methodology, frequency and any independent input.
• Reporting: whether cross-fund exposures are separately identified.
• Side letters and MFN: Proskauer describes MFNs as more often individually negotiated than embedded in the LPA, and subject to carve-outs.

The cost of flexibility

The commercial tension is straightforward. The earlier fund may need liquidity, an extension or capital it no longer has. The later fund wants a clean entry price and a fresh underwriting case. The sponsor sits between them and controls timing, price, allocation and the narrative presented to both LP groups.

Incentives diverge further because carry positions differ. A selling fund below its preferred return has a different interest in transaction price and timing than a fund already in carry. Kastiel and Nili document how continuation-fund structures create conflicts among GPs, existing LPs, incoming LPs and advisers, and note that many existing LPs decline rollover despite the sponsor relationship. Advisers running the process carry their own execution incentives, which makes process evidence more important rather than less.

The LPAC’s role and limits

ILPA describes the advisory board as a committee of LPs to which the GP delegates clearance and guidance on possible conflicts. Proskauer identifies the LP advisory board as the typical forum for resolving cross-over and follow-on conflicts, while Houlihan Lokey notes that LPs or LPACs are regularly approached to waive conflicts in affiliate transactions.

LPAs use four different asks, and treating them as interchangeable gives LPs a false sense of control:

1. Notice: the GP informs the committee, with no response required.
2. Consultation: the committee comments, while the GP retains discretion.
3. Conflict waiver: the committee removes a contractual restriction without endorsing the merits.
4. Affirmative consent: the transaction cannot proceed without a vote.

Do not assume every LPA requires consent. The mechanism also has a practical limit. An LPAC waives a conflict. It does not re-underwrite the asset, run a competing process or negotiate price in the way an arm’s-length buyer would. Members serve part-time, receive sponsor-prepared materials and may lack independent valuation resources.

Allocation policy in daily decisions

Most cross-fund questions are settled long before an LPAC meeting, by the allocation policy. A serviceable policy answers specific questions that the LPA may authorise only at a high level.

• Which vehicle has priority when strategies overlap, and on what basis.
• Whether the earlier fund must exhaust reserves before successor capital enters.
• How remaining capital, investment period status and concentration limits affect priority.
• Where co-investors sit in the queue.
• How deviations are escalated, approved and recorded.

Decisions on fund extensions, follow-on investments and recycling all require LPA authorisation, so a policy that contradicts the document is unenforceable in the part that matters. That constraint matters most late in the life cycle of a private equity fund, when reserves, fund term and successor-fund activity start to collide.

Valuation without a third-party bid

Price is the single point where an LP loses most if the process is weak. Where a genuine third-party process exists, it supplies evidence. Where it does not, the sponsor sets both the bid and the ask.

Houlihan Lokey describes independent financial advisers and fairness or valuation opinions as tools that may help sponsors manage legal, regulatory, contractual and execution risk in affiliate transactions. That should be treated as adopted practice among sponsors, not as a legal requirement.

Practical diligence points for an LP or fund CFO reviewing a proposed price include:

• Compare the transaction price to the most recent reported NAV and explain any gap.
• Check the reference date of the supporting analysis against the expected closing date.
• Test the price against public comparables and precedent transactions independently of the sponsor’s deck.
• Confirm how transaction expenses are split between the funds involved.

Reported returns and carry effects

A fund-to-fund sale moves an asset from unrealised to realised value in the selling fund. Distributed to paid-in capital rises, residual value falls, and total value may barely move. DPI improves without any external buyer validating the mark.

Carry timing follows the distribution waterfall. If the sale generates distributions that clear the preferred return and catch-up, it may accelerate carried interest for the selling fund’s GP. Model that outcome before assessing whether the timing decision was driven by portfolio logic.

On the buy side, the successor fund inherits vintage concentration risk and an asset the sponsor has already marked. If the earlier fund cannot fund its pro rata share of a follow-on, its position dilutes while the successor fund’s ownership rises. Run pro forma ownership under participation and non-participation before signing off.

Negotiation and process checklists

LPs should press the following points during fundraising, when their leverage is strongest and before a live conflict narrows the discussion:

• Express language covering cross-fund and affiliate transactions rather than reliance on a general conflicts clause.
• Advance notice periods and the standard for LPAC action.
• Disclosure of the written allocation policy before closing.
• Limits on successor-fund investment into existing portfolio companies.
• Reporting that identifies cross-fund exposures separately.
• Treatment of management fees, transaction expenses and carry on fund-to-fund transfers.
• MFN access to protections other investors negotiate.

A GP approaching the committee should assemble the business rationale, an eligibility and suitability analysis for each fund, the allocation record, valuation support, a conflicts memo separating investment merits from the waiver request, expense allocation, and the projected impact on each fund’s reported metrics.

Conclusion

The value of a cross-fund clause lies in the record it forces the sponsor to create. An LPA that grants broad discretion with a bare conflicts waiver leaves LPs with no way to test price, allocation or timing after the fact, and no basis for challenge when the successor fund’s entry price happens to validate the earlier fund’s carrying value.

Investors who wait until an LPAC deck lands have already lost the negotiation. The protections that count are drafted at closing, and their quality is measured by whether an outside reviewer could reconstruct why one fund bought and the other sold at that price on that date.

P.S. If fund structuring and conflicts analysis interest you, check out our Premium Resources for financial models, transaction decks and more tools to help you advance your career.

Sources

• Private Equity Glossary | Institutional Limited Partners Association
• Continuation Fund and Cross-Fund Transactions Remain Resilient During Volatile Markets
• The Rise of Private Equity Continuation Funds – Chicago Booth
• The Rise of Private Equity Continuation Funds
• At the negotiating table: Ts & Cs that require attention
• Limited Partnership Agreement (LPA): Definition & Key Terms – Carta
• The Anatomy of a Modern Fund Structure: LPs, GPs, & LLCs – Carta